TY - JOUR
T1 - Meeting report
T2 - 38th international conference on antiviral research in Las Vegas, United States of America, March 17–21, 2025
AU - Jordan, Robert
AU - Archin, Nancie M.
AU - Cagno, Valeria
AU - Feng, Joy Y.
AU - Guo, Haitao
AU - Herrero, Lara J.
AU - Janeba, Zlatko
AU - Meanwell, Nicholas A.
AU - Moffat, Jennifer
AU - Neyts, Johan
AU - Rocha-Pereira, Joana
AU - Seley-Radtke, Kathie L.
AU - Sheahan, Timothy P.
AU - Spengler, Jessica R.
AU - Welch, Stephen R.
AU - Xie, Xuping
AU - Zakaryan, Hovakim
AU - Schang, Luis M.
AU - Durantel, David
N1 - Publisher Copyright: © 2025 Elsevier B.V.
PY - 2025/9
Y1 - 2025/9
N2 - The 38th International Conference on Antiviral Research (ICAR), sponsored by the International Society for Antiviral Research (ISAR), took place March 17–21, 2025 in Las Vegas, Nevada, USA. The annual meeting brought together leading scientists from across academia, industry, and government to present the latest advances in antiviral research. Topics included discovery and development of novel antiviral agents, innovative therapeutic approaches, vaccine technologies, host-targeted strategies, and responses to emerging and re-emerging viral threats. ICAR 2025 featured keynote talks, short oral presentations, poster sessions and special sessions to encourage discussions between attendees and foster interdisciplinary collaboration. Several events were held to support the next generation of antiviral researchers, including dedicated sessions and networking opportunities focused on mentorship and career development for students, postdoctoral fellows, and early-career scientists. Importantly, ISAR continues to serve as a cornerstone for international collaboration and innovation in antiviral science, and the society is eager to continue these efforts at the 39th ICAR, to be held in Prague, Czech Republic, from April 27–May 1, 2026.
AB - The 38th International Conference on Antiviral Research (ICAR), sponsored by the International Society for Antiviral Research (ISAR), took place March 17–21, 2025 in Las Vegas, Nevada, USA. The annual meeting brought together leading scientists from across academia, industry, and government to present the latest advances in antiviral research. Topics included discovery and development of novel antiviral agents, innovative therapeutic approaches, vaccine technologies, host-targeted strategies, and responses to emerging and re-emerging viral threats. ICAR 2025 featured keynote talks, short oral presentations, poster sessions and special sessions to encourage discussions between attendees and foster interdisciplinary collaboration. Several events were held to support the next generation of antiviral researchers, including dedicated sessions and networking opportunities focused on mentorship and career development for students, postdoctoral fellows, and early-career scientists. Importantly, ISAR continues to serve as a cornerstone for international collaboration and innovation in antiviral science, and the society is eager to continue these efforts at the 39th ICAR, to be held in Prague, Czech Republic, from April 27–May 1, 2026.
UR - https://www.scopus.com/pages/publications/105010849156
U2 - 10.1016/j.antiviral.2025.106222
DO - 10.1016/j.antiviral.2025.106222
M3 - Review article
C2 - 40617260
SN - 0166-3542
VL - 241
JO - Antiviral Research
JF - Antiviral Research
M1 - 106222
ER -